Home > PE Ratio > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
PE (Price/Earnings) Ratio

The Current P/E Ratio of SAMRAT PHARMACHEM is 18.02.

Share Price ₹375.7Dec 26,2024
Market Cap ₹116.5 Cr
Earnings-TTM₹6.5 CrTTM-Standalone Results
Price/Earnings18.02xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results
SAMRAT PHARMACHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SAMRAT PHARMACHEM

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SAMRAT PHARMACHEM is calculated as :

Current Market Cap [ ₹116.5 Cr] as on Dec 26,2024

(/) Earnings [ ₹6.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 18.02x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SAMRAT PHARMACHEM , the investors are currently willing to pay 18.02 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAMRAT PHARMACHEM !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SAMRAT PHARMACHEM over the last five years.

Historical PE (Price/Earnings) ratio chart of SAMRAT PHARMACHEM


PE Ratio Performance Analysis for SAMRAT PHARMACHEM

- SAMRAT PHARMACHEM 's latest p/e ratio is 18.02x.

- SAMRAT PHARMACHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 15.10x.

- SAMRAT PHARMACHEM 's operated at median p/e ratio of 7.88x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SAMRAT PHARMACHEM 's p/e ratio peaked in Mar2024 at 47.64x.

- SAMRAT PHARMACHEM 's p/e ratio hit its five-year low in Mar2020 of 4.37x.


How does SAMRAT PHARMACHEM 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SAMRAT PHARMACHEM 6.4718.02116.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.67441,838.0
CIPLA LTD4,485.2226.81120,270.0
DR REDDYS LABORATORIES LTD5,406.8020.91113,077.0
ZYDUS LIFESCIENCES LTD4,298.9022.4696,553.2
DIVIS LABORATORIES LTD1,836.0085.03156,107.0
MANKIND PHARMA LTD2,124.8656.57120,212.0
TORRENT PHARMACEUTICALS LTD1,802.0064.17115,643.0
LUPIN LTD2,651.9437.5399,532.1
AUROBINDO PHARMA LTD3,598.8320.2772,945.8
ABBOTT INDIA LTD1,284.6647.3660,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAMRAT PHARMACHEM 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.02x
Max industry PE 85.03x
Median industry PE 37.53x
Average industry PE 39.89x



You may also like the below Video Courses